Ravi Rao

Ravi Rao is an experienced medical leader currently serving as a Member of the Board of Directors at Autolus Therapeutics and DBV Technologies, alongside roles as Chief Medical Officer at Sitryx and previously at Oxford Biomedica and Aeglea BioTherapeutics. In the venture capital space, Ravi Rao holds the position of Venture Partner at SV Health Investors. With a comprehensive background in immunology and rheumatology, Ravi Rao has held significant roles at GSK and Roche Pharmaceuticals, including Vice President and Group Medical Director. Educational qualifications include an MB BCh from the University of Cambridge, a PhD in Vascular Biology from Imperial College London, and additional certifications from the Royal College of Physicians and General Medical Council.